Ostlund Ingrid, Hanson Ulf
Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden.
Acta Obstet Gynecol Scand. 2004 Jan;83(1):46-51. doi: 10.1111/j.1600-0412.2004.00267.x.
To determine the value of repeated random blood glucose (R-B-glucose) measurements alone or in combination with traditional risk factors [family history of diabetes, obesity, prior large-for-gestational-age (LGA) infant or prior gestational diabetes mellitus (GDM)] to predict the outcome of the oral glucose tolerance test (OGTT).
A prospective population-based study was undertaken in a Swedish county. All pregnant nondiabetic women (n = 4918) visiting the maternal health care clinics over a 2-year period were offered a 75-g OGTT in gestational weeks 28-32. Traditional risk factors and values of repeated R-B-glucose measurements were registered, as well as the results of the OGTT, in terms of fasting B-glucose and 2-h B-glucose.
A total of 3616 women (73.5%) had an OGTT. Of these, 1.7% had GDM, 1.3% impaired glucose tolerance (IGT) and 0.4% diabetes mellitus (DM). An R-B-glucose cut-off level > or =8.0 mmol/L as the only indicator for an OGTT was optimal for detecting GDM with regard to sensitivity (47.5%) and specificity (97.0%). It has the same sensitivity for detecting GDM as using traditional risk factors, but reduces the need to carry out the OGTT from 15.8% to 3.8% of the population. Combined with prior LGA infant or prior GDM as indications for the OGTT in the present study, all women with DM and 44.7% of those with IGT will be identified. Only 7.3% of the population will have to take the OGTT.
A random B-glucose level > or = 8.0 mmol/L prior LGA infant or prior GDM as an indicator for taking the OGTT is a simple and effective first step in a two-step screening model for GDM.
确定单独重复测定随机血糖(R-B-葡萄糖)或联合传统危险因素[糖尿病家族史、肥胖、既往巨大儿(LGA)或既往妊娠期糖尿病(GDM)]预测口服葡萄糖耐量试验(OGTT)结果的价值。
在瑞典一个县进行了一项基于人群的前瞻性研究。在两年期间到产妇保健诊所就诊的所有非糖尿病孕妇(n = 4918)在妊娠28 - 32周时接受75g OGTT。记录传统危险因素、重复R-B-葡萄糖测定值以及OGTT结果,包括空腹B-葡萄糖和2小时B-葡萄糖。
共有3616名妇女(73.5%)进行了OGTT。其中,1.7%患有GDM,1.3%葡萄糖耐量受损(IGT),0.4%患有糖尿病(DM)。以R-B-葡萄糖截断水平≥8.0 mmol/L作为OGTT的唯一指标,在检测GDM方面,敏感性(47.5%)和特异性(97.0%)最佳。其检测GDM的敏感性与使用传统危险因素相同,但将进行OGTT人群的比例从15.8%降至3.8%。在本研究中,联合既往巨大儿或既往GDM作为OGTT的指征,可识别所有患有DM的妇女以及44.7%患有IGT的妇女。仅7.3%的人群需要进行OGTT。
随机B-葡萄糖水平≥8.0 mmol/L、既往巨大儿或既往GDM作为进行OGTT的指标,是GDM两步筛查模型中简单有效的第一步。